ArticleHealth SA = SA Gesondheid2026
Clinical pharmacists and drug-related problem management in a South African hospital.
Article in Health SA = SA Gesondheid, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Drug-related problems (DRPs) negatively impact health outcomes and are more likely in patients with multiple comorbidities and polypharmacy. Involving clinical pharmacists in multidisciplinary teams can improve drug safety and efficacy by preventing DRPs. Aim: This study aimed to identify and analyse DRPs and highlight the role of clinical pharmacists in minimising DRPs. Setting: This study was conducted in the internal medicine wards of a tertiary hospital in South Africa. Methods: A descriptive quantitative study was conducted using purposive sampling, including all inpatients in internal medicine wards. Drug-related problems were identified through daily reviews of patient files using a standardised pharmaceutical care form. Findings were communicated to the healthcare team. Data were analysed descriptively using Stata. Results: A total of 181 patient cases were reviewed, with most patients being male (65.2%) and aged 20-40 years (35.9%). A total of 241 DRPs were recorded, averaging 1.76 DRPs per patient. The most frequent DRP was failure to receive therapy (53.1%), often because of omitted doses. The clinical pharmacist made 277 recommendations, with 37.2% accepted by nurses and 22.7% by doctors. Conclusion: Clinical pharmacists effectively identified and addressed DRPs, particularly omitted doses and therapeutic duplication. The integration of clinical pharmacists into healthcare teams can significantly reduce DRPs and enhance patient safety. Contribution: This study raises awareness of drug-related problems and supports the development of strategies to prevent them in hospitalised patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.